These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 33588771)

  • 1. Regression models for interval censored data using parametric pseudo-observations.
    Johansen MN; Lundbye-Christensen S; Larsen JM; Parner ET
    BMC Med Res Methodol; 2021 Feb; 21(1):36. PubMed ID: 33588771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression models using parametric pseudo-observations.
    Nygård Johansen M; Lundbye-Christensen S; Thorlund Parner E
    Stat Med; 2020 Sep; 39(22):2949-2961. PubMed ID: 32519771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fast approximations of pseudo-observations in the context of right censoring and interval censoring.
    Bouaziz O
    Biom J; 2023 Apr; 65(4):e2200071. PubMed ID: 36843309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression analysis in an illness-death model with interval-censored data: A pseudo-value approach.
    Sabathé C; Andersen PK; Helmer C; Gerds TA; Jacqmin-Gadda H; Joly P
    Stat Methods Med Res; 2020 Mar; 29(3):752-764. PubMed ID: 30991888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semiparametric competing risks regression under interval censoring using the R package intccr.
    Park J; Bakoyannis G; Yiannoutsos CT
    Comput Methods Programs Biomed; 2019 May; 173():167-176. PubMed ID: 31046992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interval-censored time-to-event and competing risk with death: is the illness-death model more accurate than the Cox model?
    Leffondré K; Touraine C; Helmer C; Joly P
    Int J Epidemiol; 2013 Aug; 42(4):1177-86. PubMed ID: 23900486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Events per variable for risk differences and relative risks using pseudo-observations.
    Hansen SN; Andersen PK; Parner ET
    Lifetime Data Anal; 2014 Oct; 20(4):584-98. PubMed ID: 24420649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A flexible semiparametric modeling approach for doubly censored data with an application to prostate cancer.
    Han S; Andrei AC; Tsui KW
    Stat Methods Med Res; 2016 Aug; 25(4):1718-35. PubMed ID: 23907782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of accelerated failure time data with dependent censoring using auxiliary variables via nonparametric multiple imputation.
    Hsu CH; Taylor JM; Hu C
    Stat Med; 2015 Aug; 34(19):2768-80. PubMed ID: 25999295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of different parametric proportional hazards models for interval-censored data: a simulation study.
    Gong Q; Fang L
    Contemp Clin Trials; 2013 Sep; 36(1):276-83. PubMed ID: 23916917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrapolation of Survival Curves Using Standard Parametric Models and Flexible Parametric Spline Models: Comparisons in Large Registry Cohorts with Advanced Cancer.
    Gray J; Sullivan T; Latimer NR; Salter A; Sorich MJ; Ward RL; Karnon J
    Med Decis Making; 2021 Feb; 41(2):179-193. PubMed ID: 33349137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined estimating equation approaches for the additive hazards model with left-truncated and interval-censored data.
    Lu T; Li S; Sun L
    Lifetime Data Anal; 2023 Jul; 29(3):672-697. PubMed ID: 36959395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semiparametric efficient estimation for additive hazards regression with case II interval-censored survival data.
    He B; Liu Y; Wu Y; Zhao X
    Lifetime Data Anal; 2020 Oct; 26(4):708-730. PubMed ID: 32157479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive-multiplicative hazards regression models for interval-censored semi-competing risks data with missing intermediate events.
    Kim J; Kim J; Kim SW
    BMC Med Res Methodol; 2019 Mar; 19(1):49. PubMed ID: 30841923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of composite endpoints with component-wise censoring in the presence of differential visit schedules.
    Eaton AA; Zabor EC
    Stat Med; 2022 Apr; 41(9):1599-1612. PubMed ID: 35043427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression modeling of restricted mean survival time for left-truncated right-censored data.
    Rong R; Ning J; Zhu H
    Stat Med; 2022 Jul; 41(16):3003-3021. PubMed ID: 35708238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable selection in a flexible parametric mixture cure model with interval-censored data.
    Scolas S; El Ghouch A; Legrand C; Oulhaj A
    Stat Med; 2016 Mar; 35(7):1210-25. PubMed ID: 26467904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multiparameter regression model for interval-censored survival data.
    Peng D; MacKenzie G; Burke K
    Stat Med; 2020 Jun; 39(14):1903-1918. PubMed ID: 32329101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression analysis of arbitrarily censored survival data under the proportional odds model.
    Wang L; Wang L
    Stat Med; 2021 Jul; 40(16):3724-3739. PubMed ID: 33882618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple imputation for interval censored data with auxiliary variables.
    Hsu CH; Taylor JM; Murray S; Commenges D
    Stat Med; 2007 Feb; 26(4):769-81. PubMed ID: 16755528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.